IGC Pharma (IGC) News Today $0.34 +0.02 (+4.88%) Closing price 03:58 PM EasternExtended Trading$0.34 -0.01 (-1.75%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipSEC FilingsBuy This Stock IGC Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period IGC Pharma Introduces MINT-AD: Proprietary AI Platform to Predict ...July 12 at 4:40 PM | morningstar.comMIGC Pharma, Inc.: IGC Pharma Introduces MINT-AD: Proprietary AI Platform to Predict Alzheimer's Risk and Accelerate Early DetectionJuly 11, 2025 | finanznachrichten.deEarnings call transcript: IGC Pharma Q2 2025 sees strategic growth in Alzheimer’s research - Investing.comJuly 2, 2025 | investing.comIGC Pharma earnings matched, revenue fell short of estimatesJuly 2, 2025 | investing.comEarnings call transcript: IGC Pharma Q2 2025 sees strategic growth in Alzheimer’s research - Investing.com UKJuly 2, 2025 | uk.investing.comIGC Pharma, Inc.: IGC Pharma: Fiscal Year 2025 Financial and Operational Highlights - A Year of Transformative Progress in Alzheimer's InnovationJune 30, 2025 | finanznachrichten.deIGC Pharma, Inc.: IGC Pharma to Host Fiscal Year-End 2025 Shareholder Update Call on Monday June 30, 2025 - FinanzNachrichten.deJune 28, 2025 | finanznachrichten.deIGC Pharma to Host Fiscal Year-End 2025 Shareholder Update Call on Monday June 30, 2025 - MorningstarJune 28, 2025 | morningstar.comMIGC Pharma Inc Trailing Returns - MorningstarJune 27, 2025 | morningstar.comMIGC Pharma Inc. Annual Cash Flow Statement - MarketWatchJune 27, 2025 | marketwatch.comInsights Ahead: IGC Pharma's Quarterly EarningsJune 27, 2025 | benzinga.comIGC Pharma Expands CALMA Trial to Oklahoma, Partnering with Dr. David McCoy at Tekton Research in Yukon - MorningstarJune 24, 2025 | morningstar.comMIGC Pharma, Inc.: IGC Pharma's Puerto Rico CALMA Trial Site Offers Strategic Opportunity in High-Prevalence Alzheimer's MarketMay 22, 2025 | finanznachrichten.deOtsuka Holdings Stock Price, Quotes and Forecasts | OTC:OTSKY | BenzingaMay 22, 2025 | benzinga.comIGC Pharma, Inc.: IGC Pharma Presents Genetic Toxicology Safety Data on API in IGC-AD1, at the 2025 Genetic Toxicology Association MeetingMay 12, 2025 | finanznachrichten.deIGC Pharma announces strategic investment from advisorsApril 24, 2025 | markets.businessinsider.comIGC Pharma expands CALMA trial with addition of Butler Hospital ProgramApril 9, 2025 | markets.businessinsider.comIGC Pharma, Inc.: IGC Pharma Expands CALMA Alzheimer's Phase 2 Trial with Prestigious Research Site at Butler Hospital's Memory and Aging ProgramApril 8, 2025 | finanznachrichten.deIGC Pharma announces CALMA Phase 2 trial expansion with Miami Jewish HealthApril 2, 2025 | markets.businessinsider.comIGC Pharma expands CALMA clinical trialApril 2, 2025 | markets.businessinsider.comIGC Pharma announces additional interim results from IGC-AD1 trialMarch 28, 2025 | markets.businessinsider.comIGC Pharma announces interim data from Phase 2 trial of IGC-AD1March 28, 2025 | markets.businessinsider.comIGC Pharma, Inc.: IGC Pharma's Phase 2 Clinical Trial Interim Data Demonstrates Significant Reduction in Sleep DisturbancesMarch 27, 2025 | finanznachrichten.deIGC Pharma posts promising interim data for Alzheimer’s therapyMarch 27, 2025 | finance.yahoo.comIGC Pharma announces CALMA Phase 2 trial expansionMarch 21, 2025 | markets.businessinsider.comIGC adds new clinical site in Canada for Alzheimer’s agitation therapy trialMarch 21, 2025 | finance.yahoo.comIGC Pharma, Inc.: IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Canadian Hamilton Health SciencesMarch 20, 2025 | finanznachrichten.deIGC Pharma, Inc.: IGC Pharma Expands CALMA Trial with Addition of BayCare Health System in FloridaMarch 17, 2025 | finanznachrichten.deIGC Pharma expands CALMA trial with addition of BayCare Health SystemMarch 17, 2025 | markets.businessinsider.comIGC Pharma, Inc. (IGC) Advances AI Model to Enhance Alzheimer’s DiagnosisMarch 6, 2025 | insidermonkey.comIGC Pharma, Inc.: IGC Pharma Expands AI Platform With Advanced Diagnostic Model for Alzheimer's and Dementia DetectionMarch 4, 2025 | finanznachrichten.deIGC Pharma develops AI-driven model to improve diagnosis of Alzheimer’sMarch 4, 2025 | markets.businessinsider.comIGC Pharma reports Q3 EPS (2c) vs. (9c) last yearFebruary 20, 2025 | markets.businessinsider.comIGC Pharma expands Holiby line with ‘Longevity’, ‘Renew’February 20, 2025 | markets.businessinsider.comIGC Pharma, Inc.: IGC Pharma Reports Third Quarter Fiscal 2025 ResultsFebruary 18, 2025 | finanznachrichten.deIGC Pharma, Inc.: IGC Pharma Expands Into $75 Billion Wellness Market with the Launch of HolibyFebruary 11, 2025 | finanznachrichten.deIGC Pharma Appoints Former Virginia Governor Terry McAuliffe as Strategic AdvisorJanuary 21, 2025 | markets.businessinsider.comIGC Gains on Word of Alzheimer’s TreatmentJanuary 9, 2025 | baystreet.caIGC Pharma names IGC-AD1 Phase 2 clinical trial ‘CALMA’January 9, 2025 | markets.businessinsider.comIGC Pharma, Inc.: IGC Pharma Announces Participation in BioPartnering at JPM Alongside the J.P. Morgan 43rd Annual Healthcare Conference 2025December 20, 2024 | finanznachrichten.deIGC Pharma expands clinical research program for IGC-AD1December 2, 2024 | markets.businessinsider.comIGC Pharma Advances IGC-AD1 as a Potential Alzheimer's Therapy Addressing Cognitive Impairment and Underlying Disease PathologyDecember 2, 2024 | finance.yahoo.comIGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's TreatmentNovember 25, 2024 | businesswire.comIGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s PipelineNovember 14, 2024 | markets.businessinsider.comIGC Pharma announces publication of IMS Spotlight interviewNovember 7, 2024 | markets.businessinsider.comIGC Pharma (AMEX:IGC) Stock, Short Interest ReportSeptember 29, 2024 | benzinga.comInsider Buying: IGC Pharma, Inc. (NYSEMKT:IGC) Director Acquires 588,235 Shares of StockSeptember 28, 2024 | insidertrades.comIGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer's TreatmentSeptember 18, 2024 | finance.yahoo.comThe Analyst Verdict: IGC Pharma In The Eyes Of 4 ExpertsSeptember 4, 2024 | benzinga.comIGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer's DiseaseSeptember 4, 2024 | finance.yahoo.com Get IGC Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for IGC and its competitors with MarketBeat's FREE daily newsletter. Email Address IGC Media Mentions By Week IGC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IGC News Sentiment▼-0.180.99▲Average Medical News Sentiment IGC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IGC Articles This Week▼21▲IGC Articles Average Week Get IGC Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for IGC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Seres Therapeutics News Today Coya Therapeutics News Today OptiNose News Today OKYO Pharma News Today Zomedica News Today MacroGenics News Today TScan Therapeutics News Today Xtant Medical News Today BeyondSpring News Today XBiotech News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEMKT:IGC) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IGC Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IGC Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
